Cargando…
Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study
Background: The chronic kidney disease (CKD) population, including kidney transplant recipients (KTRs) and subjects on renal replacement therapy, is particularly vulnerable to unfavorable outcomes from chronic hepatitis C (CHC). Currently, there are oral direct-acting antiviral agents (DAAs) availab...
Autores principales: | Czarnecka, Paulina, Czarnecka, Kinga, Tronina, Olga, Bączkowska, Teresa, Wyczałkowska-Tomasik, Aleksandra, Durlik, Magdalena, Czerwinska, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219487/ https://www.ncbi.nlm.nih.gov/pubmed/37240622 http://dx.doi.org/10.3390/jcm12103513 |
Ejemplares similares
-
Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
por: Czarnecka, Paulina, et al.
Publicado: (2022) -
Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation
por: Czarnecka, Kinga, et al.
Publicado: (2021) -
Are We on the Right Track for HCV Micro-Elimination? HCV Management Practices in Dialysis Centers in Poland—A National Cross-Sectional Survey
por: Czarnecka, Paulina, et al.
Publicado: (2023) -
Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting—A Single Center Experience
por: Czarnecka, Kinga, et al.
Publicado: (2022) -
Real-life comparison of efficacy and safety profiles of two prolonged-release tacrolimus formulations in de novo kidney transplant recipients: 24 months of follow-up
por: Czarnecka, Paulina, et al.
Publicado: (2023)